Concepedia

Publication | Open Access

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

172

Citations

43

References

2006

Year

Abstract

The results suggest that, in early breast cancer, MUC1 immunotherapy is beneficial, and that a larger phase III study should be undertaken.

References

YearCitations

Page 1